From April 9 to 12, 2026, the 93rd China International Medical Equipment Fair (CMEF) will be grandly inaugurated at the National Exhibition and Convention Center (Shanghai). As a “leading indicator” and “barometer” of the global healthcare industry, this year’s exhibition is themed “Innovation Convergence, Infinite Leapfrogging,” bringing together nearly 5,000 brand-name companies from more than 20 countries and regions worldwide. These include multinational giants such as GE Healthcare and Siemens Healthineers, as well as numerous Chinese innovators specializing in niche segments. The event has attracted over 200,000 professional visitors, buyers, and industry peers from 150 countries and regions, all coming together to witness groundbreaking advances in medical technology and the vibrant momentum of industrial development. Shandong Haizhou Medical Technology Co., Ltd. (hereinafter “Haizhou Medical”) showcased its core laparoscopic surgical instruments with great success. Backed by the robust product quality of its flagship offerings—such as needle holders, laparoscopic scissors, and laparoscopic grasping forceps—Haizhou Medical has not only matched but in many cases surpassed the standards set by leading international brands, earning widespread acclaim from global trade visitors. The company secured numerous on-site orders and signed strategic cooperation agreements with partners across Southeast Asia, South America, Europe, Central Asia, and South Asia, establishing itself as a shining benchmark for Chinese medical devices expanding into overseas markets at this year’s exhibition.

As the first global "aircraft carrier" medical flagship exhibition in the opening year of the "Tenth 5", this CMEF is deeply connected with the national health China strategy and medical science and technology innovation plan, setting up core exhibition areas such as medical consumables, minimally invasive surgery and medical imaging, and adding future science and technology exhibition areas to present the innovation ecology of the whole medical and health industry chain in an all-round way. For many years, Haizhou Medical has been deeply engaged in the R&D, manufacturing, sales, and service of laparoscopic minimally invasive surgical instruments. At this year’s exhibition, the company aligned closely with the event’s innovation-driven theme, focusing on the core clinical needs of general surgery, thoracic surgery, gynecology, and other specialties. It prominently showcased its key products, including needle holders, laparoscopic scissors, and laparoscopic grasping forceps, comprehensively highlighting the fine craftsmanship and meticulous quality of a leading Chinese medical device manufacturer in the field of minimally invasive instrumentation, thereby breaking the long-standing monopoly held by top-tier international brands in this sector.

At the exhibition site, the popularity of Haizhou Medical Booth continued to rise, becoming a key booth for international merchants to stop for consultation and cooperation. Its core products have become the focus of the audience, and have won unanimous praise from global merchants for their excellent quality. According to the on-site staff, Haizhou Medical's needle holder is precision made of medical 630 stainless steel, ergonomic straight handle with lock buckle design, stable jaw clamping, accurate operation, strong and durable; In terms of suture accuracy and operation feel, it is completely comparable to Germany's STORZ, WOLF and other first-line brands. Some performance indexes even surpass those of various fine suture surgery requirements under laparoscopic adaptation.

At the same time, the laparoscopic scissors and laparoscopic grasping forceps showed the same bright eye. The laparoscopic scissors feature a 360°‑rotating, double‑action blade design, with exceptionally sharp edges and superior toughness, enabling precise cutting and dissection. They also offer excellent insulation to prevent thermal injury during electrocautery, while their durability and operational flexibility far exceed industry averages. The laparoscopic grasping forceps employ a non‑invasive, non‑slip design, ensuring gentle tissue apposition without mucosal damage. Their 360° rotational capability accommodates diverse surgical perspectives, and they meet international advanced standards in clamping stability and service life, fully capable of replacing comparable imported products. A number of surgical experts and purchasers from Europe and Southeast Asia spoke highly of Haizhou Medical's products after on-site operation demonstration and performance comparison test. They said that their quality was not inferior to that of international first-line brands, and had higher cost performance and more convenient after-sales service.

With excellent product quality, Haizhou Medical has successfully signed strategic cooperation agreements with high-quality merchants in Japan and South Korea, Southeast Asia, South America, Europe, Central Asia, South Asia and other regions. The two sides will carry out in-depth cooperation around product supply, market expansion and technology optimization, so as to promote Haizhou medical laparoscopic instruments to enter the global market in an all-round way, Help domestic minimally invasive instruments to achieve international layout. The achievement of this strategic cooperation has not only broadened the overseas market channels of Haizhou Medical, but also demonstrated the core competitiveness of domestic medical devices in the global market, and laid a solid foundation for China's minimally invasive devices to go to sea.

As a locally rooted medical technology company based in Jinan, Shandong, Haizhou Medical has, since its establishment in 2020, consistently upheld the business philosophy of “quality first, integrity and innovation, and win‑win cooperation.” Leveraging a dedicated R&D team and a robust production system, the company has continuously intensified its efforts to master core technologies, focusing on clinical needs to optimize product design and manufacturing processes, and has developed the highmeda brand.®Brand Laparoscopic Instruments Brand. Through this exhibition, Haizhou Medical not only showcased the company’s innovative achievements and product strength, but also leveraged CMEF, a global exchange platform, to engage in in-depth discussions with industry peers worldwide on technological trends and development directions in the field of minimally invasive medicine, while gaining insights into international market demands and accumulating valuable experience for optimizing the internationalization of its subsequent products.

During the exhibition, Haizhou medical exhibition team also actively participated in hundreds of high-end academic conferences and international cooperation forums held at the same time, focusing on the intelligent and accurate development trend of minimally invasive surgical instruments, as well as the international trade trends of global medical devices, learning from the advanced technologies and concepts of domestic and foreign counterparts, and injecting new impetus into the follow-up technological innovation and industrial upgrading of enterprises. In the current industry landscape—marked by accelerating domestic substitution in medical devices and evolving global market demands—Haizhou Medical stated that it will seize this exhibition as an opportunity to remain steadfastly committed to breakthroughs in core technologies, continuously enhance product quality and competitiveness, and deepen strategic partnerships with international clients. By expanding its overseas presence, Haizhou aims to bring China‑made laparoscopic instruments to the global stage, enabling healthcare institutions in more countries and regions to benefit from the high‑quality achievements of Chinese medical technology.

The successful conclusion of the 93rd CMEF opened a new journey of international development for Haizhou Medical. Looking ahead, Haizhou Medical will remain true to its commitment to innovation, deepen its expertise in the field of minimally invasive medicine, continuously enhance product quality and drive technological breakthroughs, refine its global service network, and steadily expand its international market share. By doing so, it will contribute to the high-quality development of China’s medical device industry, safeguard global health with professional excellence, and usher in a new chapter for Chinese‑made medical devices on the world stage.